After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

Additional Phase 1 Data for FT819 Off-the-Shelf CAR T-cell Product Candidate in Moderate-to-Severe Systemic Lupus ...

Financially, Creative Medical has limited cash reserves, high cash burn, and will likely need dilutive financing. Click here ...

Parkinson's disease (PD) is a disabling neurodegenerative disease that affects approximately 10 million people worldwide, ...

Trailhead Biosystems Inc. ( a biotechnology company advancing human cell innovation, has secured $20 million in financing. Trailhead specializes in precisely differentiating induced pluripotent stem ...

Pluripotent stem cells are cells that have the capacity to self-renew by dividing and to develop into the three primary germ cell layers of the early embryo and therefore into all cells of the ...

Our ultimate goal is to enhance the prevalence of regenerative medicine by establishing iPS cell banking services for individuals and making iPS cells accessible to other development companies working ...

Press release photo Bangladesh Medical University pro-vice-chancellor, research and development, Professor Md Mujibur Rahman Hawlader on Tuesday said that a stem cell bank would be launched at the ...

A Phase I/II trial by Japan’s Kyoto University Hospital and the Center for iPS Cell Research and Application (CiRA) researcher and clinician team has demonstrated encouraging outcomes with the use of ...